Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Treatment of hepatitis C with peginterferon and ribavirin in Iceland from 2002-2012].

Laeknabladid - 1 Jan 2000

Fridriksson Benedikt, Bergmann Ottar Mar, Olafsson Sigurdur

Abstract excerpt

BACKGROUND/AIMS: Hepatitis C is a major cause of chronic liver disease and cirrhosis in Western countries. Its treatment aims at eradicating the virus and patients are considered cured if the virus is undetectable by PCR in blood 12-24 weeks after end of treatment (sustained virological response, SVR). The aim of this study is to investigate the results of treating hepatitis C in Iceland during the period...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hospitals, University
Share to Iceland
Share to Interferons

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Cirrhosis

Share to Medical Records

Share to Polyethylene Glycols

Share to Ribavirin

Share to Sustained Virologic Response

Source

Identifiers

PMID: 28262630
DOI: 10.17992/lbl.2017.03.126

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

[Treatment of hepatitis C with peginterferon and ribavirin in Iceland from 2002-2012].PMID 28262630Read ↗

Hepatitis C treatment at three Norwegian hospitals 2000-2011.Semantic proximity Read ↗

[Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection].Semantic proximity Read ↗

Efficacy of peginterferon alpha-2A and ribavirin combination therapy in treatment-naive Estonian patients with chronic hepatitis C.Semantic proximity Read ↗

Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy : Final results of the Austrian PegHope study.Semantic proximity Read ↗

[Markers of hepatitis C and its various genotypes in patients from Novosibirsk].Semantic proximity Read ↗

[Predictive factors of response to peginterferon and ribavirin in Tunisians patients with chronic hepatitis C: report of 141 cases].Semantic proximity Read ↗

Boceprevir in genotype 1 chronic hepatitis C: first experiences in Serbia.Semantic proximity Read ↗

[The pegasys using and HCV genotype were the independent predictors of the response to antiviral therapy in chronic hepatitis C].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.